Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice

Although dipeptidyl peptidase 4 (DPP4) is an adipokine known to positively correlate with adiposity, the effects of pharmacological DPP4 inhibition on body composition have not been fully understood. This study was aimed to assess the effects of DPP4 inhibitors on adiposity for the first time in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Yu-Na, Kim, Tae-Hyoung, Kim, Mi-Kyung, Shin, Chang-Yell, Jung, Il-Hoon, Sohn, Yong Sung, Son, Moon-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669177/
https://www.ncbi.nlm.nih.gov/pubmed/26633898
http://dx.doi.org/10.1371/journal.pone.0144064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669177/
https://www.ncbi.nlm.nih.gov/pubmed/26633898
http://dx.doi.org/10.1371/journal.pone.0144064

Ejemplares similares